介质腺素SFRP5缓解了肠上皮细胞亡,改善了克罗恩病中的屏障功能障碍
Xiaofeng Zhang1,2,3, Lugen Zuo2,3,4, Xue Song1,2,3
1Department of Central Laboratory, First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
分泌的纹相关蛋白5 (SFRP5) 增加克罗恩病 (CD) 中肠脂肪,通过减少上皮细胞亡来保护肠道屏障. 这为CD治疗提供了一个新的治疗点.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 脂肪组织生物学 脂肪组织生物学
背景情况:
- 克罗恩病 (CD) 中的炎症涉及高性介质脂肪组织 (htMAT).
- 来自htMAT的阿迪波金如何影响肠道炎症的确切机制尚不清楚.
- 分泌的纹相关蛋白5 (SFRP5) 是一种具有已知的细胞保护性质的阿迪波金.
研究的目的:
- 研究SFRP5在CD患者的htMAT中的表达和作用.
- 在CD模型中确定SFRP5对肠道屏障功能的影响.
- 阐明SFRP5在肠道中的作用背后的分子机制.
主要方法:
- 从CD患者的htMAT中分析SFRP5表达的分析.
- 评估SFRP5在患病的肠道组织中的定位.
- 使用TNF-α刺激的结肠器官的体外研究.
- 在体内研究使用TNBS诱导的大肠炎的小鼠模型.
主要成果:
- 在CD患者的htMAT中,SFRP5水平升高,局部到肠道上皮细胞.
- 在有机体和小鼠模型中,SFRP5改善了肠道屏障功能障碍.
- 部分原因是SFRP5的保护作用阻碍了表皮细胞中Wnt5a介导的亡.
结论:
- 在克罗恩病的背景下,SFRP5在保护肠道屏障方面发挥着重要作用.
- 像SFRP5一样的中肠腺皮素可以影响肠炎的进展.
- 向介质通路,特别是SFRP5,为CD提供了一个新的治疗策略.
更多相关视频
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Renewal of Intestinal Stem Cells
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
